Scryb (XCNQ:SCYB) Common Stock : C$54.05 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Scryb Common Stock?

Scryb's quarterly common stock declined from Jun. 2023 (C$54.00 Mil) to Sep. 2023 (C$53.43 Mil) but then increased from Sep. 2023 (C$53.43 Mil) to Dec. 2023 (C$54.05 Mil).

Scryb's annual common stock declined from Sep. 2021 (C$44.91 Mil) to Sep. 2022 (C$44.58 Mil) but then increased from Sep. 2022 (C$44.58 Mil) to Sep. 2023 (C$53.43 Mil).

Scryb Common Stock Historical Data

The historical data trend for Scryb's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scryb Common Stock Chart

Scryb Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Common Stock

Get a 7-Day Free Trial

18.65

21.96

44.91

44.58

53.43

Scryb Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															44.37	50.70	54.00	53.43	54.05

Scryb Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Scryb (XCNQ:SCYB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Scryb Inc (XCNQ:SCYB) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

SCYRF:USA EIY:Germany

Address

65 International Boulevard, Suite 202, Etobicoke, ON, CAN, M9W6L9

Website

https://www.scryb.ai

Scryb Inc is a platform that powers businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The platform boasts adaptability across diverse markets, from digital health and diagnostics to cybersecurity and manufacturing. The company's technologies include Cybeats, The Fionet (FRR), and Pharmatrac.

Executives

William Gordon Clark Kent

Director, Senior Officer